Brit group CEO heads back to business after cancer battle
Matthew Wilson is to resume his role as group chief executive officer (CEO) of global specialty re/insurer Brit after a year's medical leave.
Matthew Wilson is to resume his role as group chief executive officer (CEO) of global specialty re/insurer Brit after a year's medical leave.
Wilson had taken a leave of absence in September 2021 to undergo treatment for a rare form of blood cancer. He will return to work on September 12.
Martin Thompson, who has been serving as interim Group CEO, will remain on the Board of Brit Syndicates, Brit’s Lloyd’s managing agent.
Wilson said: “I’d like to thank everyone for the messages of support I’ve received over the last twelve months, it’s meant a huge amount to me and my family. Thank you to everyone at Brit for not missing a beat, I can’t wait to be back. I am also delighted that Martin, who stepped in so ably at short notice, will remain on the Brit Syndicates Limited Board and that we will continue to benefit from his experience and insight.”
Thompson said: “This is the best possible news for everyone at Brit and we could not be more excited to see Matthew return. The courage he has shown in fighting his illness and determination to return is truly inspiring. I have seen first-hand both Brit’s unique culture and the benefits of its clear strategic focus on leadership, innovation and distribution. As the architect of this strategy and culture, Matthew’s return will be a boost for the whole organisation. O n behalf of everyone at Brit, welcome back Matthew!”
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
